85 new jobs are created as BD expands its Wexford medtech manufacturing facility.
With locations in Dublin, Drogheda, and Limerick, BD has been an employer in Ireland for many years. It has invested €4 million in a new R&D facility in Dublin.
The medtech multinational BD has revealed that it would be making two major multimillion-euro investments in its businesses in Ireland.
The corporation is investing €30 million in enlarging its Enniscorthy, Co. Wexford, manufacturing site. In order to simplify the production of medical technology by BD’s Peripheral Intervention business unit, it plans to construct an extra 40,000 square feet of space.
According to the business, the investment would bring more than 85 new jobs to Wexford.
Along with the Wexford investment, BD also marked the opening of its new €4 million research and development facility in Blackrock, County Dublin.
The commercialisation of BD’s first on-body injector technology will be the main focus of the Dublin centre. The staff will collaborate closely with the 300-person Limerick R&D site, which houses BD’s other R&D facility.
At the inauguration ceremony for the Dublin building, BD shared the news about the Wexford expansion and job openings.
Since 1964, BD has operated in Ireland. Since then, it has opened four facilities across the nation, employing more than 1,100 personnel. The government is funding this new investment through IDA Ireland.
In 2021, BD increased both the size of its Drogheda presence and the size of its Limerick R&D facility, adding a total of over 200 positions to both.
Find out more about BD in Ireland.